Kazuyuki Hamada

3PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 27, 2026
Efficacy and safety of necitumumab and pembrolizumab combination therapy in advanced non-small-cell lung cancer with ≥50% PD-L1 expression: A nonrandomized phase II trial.

|Jan 23, 2024
Nivolumab receptor occupancy on effector regulatory T cells predicts clinical benefit.

Masahiro Hosonuma, Yuya Hirasawa, Atsuo Kuramasu

|Aug 26, 2022
Emerging Immune-Monitoring System for Immune Checkpoint Inhibitors.

Kazuyuki Hamada, Takuya Tsunoda, Kiyoshi Yoshimura

Pageof 1

Frequent Collaborators

2 joint publications

Takuya Tsunoda

2 joint publications

Ryotaro Ohkuma

2 joint publications

Satoshi Wada

2 joint publications

Kiyoshi Yoshimura